[1] Ganem D, Prince AM. Hepatitis B virus infection--natural history and clinical consequences. N Engl J Med, 2004, 350: 1118-1129. [2] Dienstag JL. Hepatitis B virus infection. N Engl J Med, 2008, 359: 1486-1500. [3] Wang S, Chen Z, Hu C, et al. Hepatitis B virus surface antigen selectively inhibits TLR2 ligand-induced IL-12 production in monocytes/macrophages by interfering with JNK activation. J Immunol, 2013, 190: 5142-5151. [4] Kosinska AD, Pishraft-Sabet L, Wu W, et al. Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine models. Hepatology, 2017, 66:69-83. [5] Fang Z, Li J, Yu X, et al. Polarization of monocytic myeloid-derived suppressor cells by hepatitis B surface antigen is mediated via ERK/IL-6/STAT3 signaling feedback and restrains the activation of T cells in chronic hepatitis B virus infection. J Immunol, 2015, 195: 4873-4883. [6] Loggi E, Bihl FK, Cursaro C, et al. Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels. PLoS One, 2013, 8: e65327. [7] Skrastina D, Bulavaite A, Sominskaya I, et al. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers. Vaccine, 2008, 26: 1972-1981. [8] Hruska JF, Robinson WS. The proteins of hepatitis B Dane particle cores. J Med Virol, 1977, 1: 119-131. [9] Yang PL, Althage A, Chung J, et al. Hydrodynamic injection of viral DNA: a mouse model of acute hepatitis B virus infection. Proc Natl Acad Sci U S A, 2002, 99: 13825-13830. [10] Chisari FV. Hepatitis B virus transgenic mice: models of viral immunobiology and pathogenesis. Curr Top Microbiol Immunol, 1996, 206: 149-173. [11] Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol, 2006, 1: 23-61. [12] Chuai X, Wang W, Chen H, et al. Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection. Antiviral Res, 2014, 101: 68-74. [13] Liang TJ. Hepatitis B: the virus and disease. Hepatology, 2009, 49: S13-S21. [14] Glebe D, Urban S. Viral and cellular determinants involved in hepadnaviral entry. World J Gastroenterol, 2007, 13: 22-38. [15] Yan H, Zhong G, Xu G, et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife, 2012, 1: e49. [16] Wu PC, Lam KC. Cytoplasmic hepatitis B surface antigen and the ground-glass appearance in hepatocellular carcinoma. Am J Clin Pathol, 1979, 71: 229-234. [17] Reifenberg K, Hildt E, Lecher B, et al. IFNgamma expression inhibits LHBs storage disease and ground glass hepatocyte appearance, but exacerbates inflammation and apoptosis in HBV surface protein-accumulating transgenic livers. Liver Int, 2006, 26: 986-993. |